Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.180
0.00 (0.00%)
Jan 21, 2025, 4:00 PM EST - Market closed
Artelo Biosciences Employees
Artelo Biosciences had 6 employees as of December 31, 2023. The number of employees decreased by 1 or -14.29% compared to the previous year.
Employees
6
Change (1Y)
-1
Growth (1Y)
-14.29%
Revenue / Employee
n/a
Profits / Employee
-$1,520,167
Market Cap
3.81M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
ARTL News
- 8 days ago - Artelo Biosciences Announces Successful Completion of First Cohort in a Phase 1 Study of ART26.12 - GlobeNewsWire
- 6 weeks ago - Artelo Biosciences Announces Presentation of Phase 1 Data with ART27.13 in Cancer-Related Anorexia - GlobeNewsWire
- 2 months ago - Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit - GlobeNewsWire
- 2 months ago - Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13th Annual Musculoskeletal Repair and Regeneration Symposium - GlobeNewsWire
- 2 months ago - Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health's “Preclinical Screening Platform for Pain” Program - GlobeNewsWire
- 3 months ago - Artelo Biosciences CEO to Participate in Fireside Chat at the Maxim Group Virtual Healthcare Summit on October 16th - GlobeNewsWire
- 4 months ago - Artelo Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 5 months ago - Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire